Digital Microfluidics Nucleic Acid Analysis System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nucleic acid diagnostics systems face challenges with long detection times, low sensitivity, and limited ability to detect multiple targets, which hinders efficient and accurate analysis in medical diagnostics.
Innovation Solution
An integrated nucleic acid analysis system utilizing digital microfluidics (DMF) devices for magnetic bead-based extraction, purification, thermal amplification, and fluorescence measurement, enabling high sensitivity, multiple target detection, and reduced manual processing steps.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional nucleic acid diagnostics systems are used, then detection can be performed, but detection time is long and sensitivity is low
Solution Approach 1:
The patent combines multiple nucleic acid detection targets into a single integrated diagnostic system that processes all targets simultaneously in one reaction chamber. This merging of detection functions allows parallel processing of multiple nucleic acid sequences, reducing total detection time while maintaining high sensitivity for each target through optimized reaction conditions and fluorescent labeling.
Solution Approach 2:
The system performs preliminary actions by pre-synthesizing fluorescently labeled probes and primers specific to each nucleic acid target before the detection reaction begins. These pre-prepared reagents are loaded into the reaction chamber in advance, allowing the actual detection to proceed rapidly without time-consuming preparation steps during the assay, thus reducing overall detection time while maintaining sensitivity.
2Reliability
If manual processing steps are used, then flexibility is maintained, but human errors and cross-contamination increase
Solution Approach 1:
The integrated diagnostic system performs self-service by automatically executing the complete detection protocol without requiring manual intervention. The system autonomously performs sample loading, reagent dispensing, temperature cycling, fluorescent signal acquisition, and data analysis. This automation eliminates human errors and cross-contamination risks associated with manual handling, significantly improving diagnostic reliability while the system's integrated design keeps the overall complexity manageable through unified control software.
Solution Approach 2:
The patent replaces manual mechanical operations with automated electronic control systems. Mechanical steps such as pipetting, heating, cooling, and signal detection are performed by electronic controllers and integrated sensors rather than manual operations. This substitution of mechanical processes with automated electronic systems eliminates human error and contamination risks, improving reliability while the integration of these automated functions into a single system manages complexity through centralized control.
3Adaptability or versatility
If multiple nucleic acid targets are detected simultaneously, then diagnostic capability is enhanced, but system complexity increases
Solution Approach 1:
The integrated diagnostic system achieves universality by designing a single reaction chamber and detection platform that can simultaneously detect multiple different nucleic acid targets. The system uses universal fluorescent detection mechanisms that can identify different targets through their specific fluorescent signals, allowing one system to perform multiple detection functions. This multi-functionality enhances diagnostic capability while the unified system design prevents complexity from multiplying, as all targets are processed through the same integrated platform rather than requiring separate systems for each target.
Data Source
AI summary
The present invention provides a method for integrating a nucleic acid analysis system and measuring at least one target nucleic acid in a sample. The integrated nucleic acid analysis system includes one DMF device, which includes a substrate, a cover plate, and an instrument for performing a series of operations including magnetic beads based nucleic acid extraction, purification, thermal amplification, and optical measurement of nucleic acids in samples in a DMF device. The nucleic acid extraction and purification are based on the magnetic bead method, which uses instruments to move magnetic beads in different functional areas of the digital microfluidic chip, such as lysis reservoirs, cleaning reservoirs, and elution reservoirs, etc. The present invention integrates sample processing and detection on the same microfluidic chip, and the entire process is automatically completed by the corresponding instrument. Its advantages include reducing manual errors, reducing cross contamination, and improving detection speed.